Real‐world outcomes of advanced melanoma patients not represented in phase III trials

The aim was to provide evidence on systemically treated patients with advanced melanoma not represented in phase III trials to support clinical decision‐making. Analysis were performed on advanced melanoma patients diagnosed between 2014 and 2017 in the Netherlands, treated with immune‐ or targeted...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Cancer
Hlavní autoři: van Zeijl, Michiel C. T., Ismail, Rawa K., de Wreede, Liesbeth C., van den Eertwegh, Alfonsus J. M., de Boer, Anthonius, van Dartel, Maaike, Hilarius, Doranne L., Aarts, Maureen J. B., van den Berkmortel, Franchette W. P. J., Boers‐Sonderen, Marye J., de Groot, Jan‐Willem B., Hospers, Geke A. P., Kapiteijn, Ellen, Piersma, Djura, van Rijn, Rozemarijn S., Suijkerbuijk, Karijn P. M., ten Tije, Albert J., van der Veldt, Astrid A. M., Vreugdenhil, Gerard, Haanen, John B. A. G., Wouters, Michel W. J. M
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Inc. 2020
Témata:
Cancer Therapy and Prevention
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689762/
https://ncbi.nlm.nih.gov/pubmed/32559817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.33162
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky